Traws Pharma, Inc. Share Price (NASDAQ: TRAW)

Traws Pharma, Inc. Stock Performance

as on October 14, 2025 at 1:29 am IST

Day's Low
Day's High
$2.8
Day's Price Range
$3.01
$2.92
4.11%
Downside
3.08%
Upside
52 Week's Low
52 Week's High
$0.97
52-Week Price Range
$19.44
$2.92
66.78%
Downside
565.75%
Upside

Traws Pharma, Inc. share price movements today

Previous Close: $3.01
Open: $2.90
Volume: 1.1M
Day's Low - High: $2.8 - $3.01
52 Week Low - High: $0.97 - $19.44

Traws Pharma, Inc. Historical Returns

1 Month Return: + 51.83 %
3 Month Return: + 88.31 %
1 Year Return: -42.11 %
3 Year Return: 0 %
5 Year Return: 0 %

Traws Pharma, Inc. Stock Fundamentals & Key Indicators

Check Traws Pharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.72

Industry PE ratio

PEG Ratio

EBITDA

-20.3M

Revenue (TTM)

2.9M

Profit Margin

0.00%

Return On Equity TTM

-248.20%

Traws Pharma, Inc. Stock Valuation

Track how Traws Pharma, Inc. P/E has moved over time to understand its valuation trends.

Traws Pharma, Inc. in the last 5 years

Overview
Trends

Lowest (-2.89x)

June 30, 2024

Industry (0.00x)

October 14, 2025

Today (0.72x)

October 14, 2025

Highest (0.44x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.72x

Traws Pharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Traws Pharma, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Traws Pharma, Inc.	BUY	$21.4M	NA	0.72	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.3B	223.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.6B	50.07%	28.98	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	-7.17%	14.23	31.37%

Stock Returns calculator for Traws Pharma, Inc. Stock including INR - Dollar returns

The Traws Pharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Traws Pharma, Inc. investment value today

Current value as on today

₹63,889

Returns

₹36,111

(-36.11%)

Returns from Traws Pharma, Inc. Stock

₹41,717 (-41.72%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Traws Pharma, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Traws Pharma, Inc.. Average target price of $6.5

Traws Pharma, Inc. Share Price Target

Get share price movements and forecasts by analysts on Traws Pharma, Inc..

What analysts predicted

55.08%UPSIDE

Target Price

$6.5

Current Price

$2.92

Analyzed by

8 Analysts

Target

$6.50

Traws Pharma, Inc. target price $6.5, a slight upside of 55.08% compared to current price of $2.92. According to 8 analysts rating.

Traws Pharma, Inc. Stock’s Investor Sentiment and Interest

Search interest for Traws Pharma, Inc. Stock has increased by 120% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 14, 2025 to October 14, 2025

Change:120% versus previous 30 day period

Traws Pharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	2
Gross Profit	0	0	0	0	0	0	0	0	0	2
Operating Income	-6	-4	-5	-4	-5	-5	-8	-29	-5	-1
EBITDA	-5	-4	-4	-4	-4	-123	-8	-29	21	0
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-4	-4	-4	-4	-123	-8	-29	21	0
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-5	-4	-4	-4	-4	-123	-8	81	15	0
Net Profit Margin	-10312.50%	-7456.14%	-8314.04%	-7471.43%	-8898.21%	-216040.35%	-14868.42%	146298.21%	26461.40%	-33.48%

Traws Pharma, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	5	0	1	2	0	0	0	0	0
Gross Profit	11	5	0	1	2	0	0	0	0	0
Operating Income	-23	-23	-25	-23	-21	-24	-16	-19	-20	-49
EBITDA	-23	-19	-23	-20	-21	-25	-16	-18	-18	-166
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	0	0	0	0	0
Income Before Tax	-24	-19	-24	-20	-21	-25	-16	-18	-18	-166
Income Tax Expense	0	0	0	0	0	0	0	0	0	-
Net Income	-23	-19	-24	-20	-21	-25	-16	-18	-18	-54
Net Profit Margin	-209.31%	-354.62%	-3061.25%	-1675.33%	-985.02%	-10890.48%	-7151.77%	-8391.15%	-8384.07%	-24192.04%

Traws Pharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-4	-4	-4	-123	-8	-29	21	20,553
Operating Cash Flow	-4	-4	-4	-4	-9	-11	-4	-5	-5
Investing Cash Flow	-	0	-	-	-3	-	-	-	-
Financing Cash Flow	-	-	-	-	13	-	19	0	3
Change in Cash	-4	-4	-4	-4	0	-11	15	-5	-2

Traws Pharma, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-24	-20	-21	-25	-16	-18	-18	-166
Operating Cash Flow	-15	-23	-22	-20	-23	-19	-16	-17	-29
Investing Cash Flow	-	-	-	0	0	-	-	0	-3
Financing Cash Flow	17	6	35	26	19	55	-	-	33
Change in Cash	1	-17	12	5	-3	36	-16	-17	0

Insights on Traws Pharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 56.0K → 2.73M (in $), with an average increase of 49.8% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, TRAW stock has moved up by 16.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 106.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 81.92M → -915.0K (in $), with an average decrease of 93.8% per quarter

About Traws Pharma, Inc.

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.

Organisation	Traws Pharma, Inc.
Headquarters	12 Penns Trail, Newtown, PA, United States, 18940
CEO	Dr. Iain D. Dukes DPHIL, M.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Traws Pharma, Inc.

Name	Title
Dr. Charles David Pauza Ph.D.	Chief Scientific Officer of Virology
Dr. Victor Moyo M.D.	Chief Medical Officer of Oncology
Dr. Iain D. Dukes DPHIL, M.A., Ph.D.	CEO, Secretary & Director
Mr. Charles Parker	Chief Financial Officer
Dr. Nikolay Savchuk Ph.D.	COO & Director
Dr. Robert R. Redfield M.D.	Chief Medical Officer

FAQs

What is Traws Pharma, Inc. share price today?

Traws Pharma, Inc. share price today is $2.92 as on October 14, 2025 at 1:29 am IST at the close of the market. Traws Pharma, Inc. share today touched a day high of $3.01 and a low of $2.8.

What is the 52 week high and 52 week low for Traws Pharma, Inc. share?

Traws Pharma, Inc. share touched a 52 week high of $19.44 on December 23, 2024 and a 52 week low of $0.97 on May 15, 2025. Traws Pharma, Inc. stock price today i.e. October 14, 2025 at 1:29 am IST is closed at $2.92,which is 84.98% down from its 52 week high and 201.03% up from its 52 week low.

What is Traws Pharma, Inc.'s market capitalisation today?

Traws Pharma, Inc. market capitalisation is $0.00T as on October 14, 2025 at 1:29 am IST.

How to invest in Traws Pharma, Inc. Stock (TRAW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Traws Pharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Traws Pharma, Inc. Shares that will get you 0.5137 shares as per Traws Pharma, Inc. share price of $2.92 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Traws Pharma, Inc. Stock (TRAW) from India?

Indian investors can start investing in Traws Pharma, Inc. (TRAW) shares with as little as ₹88.635 or $1 (as of October 14, 2025 at 4:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Traws Pharma, Inc. stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 4:42 pm IST). Based on Traws Pharma, Inc. share’s latest price of $2.92 as on October 14, 2025 at 1:29 am IST, you will get 3.4247 shares of Traws Pharma, Inc.. Learn more about fractional shares .